RSK1/RSK2/RSK3 (32D7) Rabbit mAb 9355S from Cell Signaling Technology

Product Specs
ItemRSK1/RSK2/RSK3 (32D7) Rabbit mAb
CompanyCell Signaling Technology
Price $339.00 Inquire
Catalog Number9355S
Quantity100 µl
ApplicationsW, IP
ReactivityH, M, R, Mk, GP
HostRabbit
ClonalityMonoclonal
TargetRSK2;RSK3;RSK1
NCBI Full Gene Nameribosomal protein S6 kinase A2, ribosomal protein S6 kinase A3, ribosomal protein S6 kinase A1
NCBI Gene AliasesMAPKAPK1C, MAPKAPK1B, MAPKAPK1A, ISPK-1, RSK1, RSK2, RSK3, MAPKAPK1, p90RSK2, XLID19, MRX19, p90Rsk, pp90RSK3, pp90RSK2, S6K-alpha3, S6K-alpha2, CLS, RSK, HU-2, HU-3, HU-1, S6K-alpha, p90-RSK2, p90-RSK3
Research AreaMAP Kinase Signaling
IsotypeIgG
Clone32D7
Molecular Weight90

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 RearrangementsbioRxivJanuary 30, 2026Ashutosh Tiwari, Utkarsha Paithane, Jordan Friedlein, Kojiro Tashiro, Olivier Saulnier, Karina Barbosa, Quang Trinh, Bryan Hall, Shrawantee Saha, Aditi Soni, et al.anti-Phospho-p90RSK (Ser380) (Cell Signaling Technology, 11989), anti-RSK1/RSK2/RSK3 (Cell Signaling Technology, 9355), Anti-Rabbit IgG, HRP-linked Antibody (Cell Signaling Technology, 7074). Anti-FFX (Firefox) monoclonal

(2) Discovery, delineation, and therapeutic targeting of a hyper-translation pathway driving cytokine release syndromeCell Reports MedicineJanuary 20, 2026Xingxian Liu, Jiaqi Li, Yajing Zhang, Yang Liu, Chunmeng Wang, Yao Wang, Yunqi Liu, Yuzhuo Yang, Yao Su, Youxue Lu, et al.(CST, 9272), p38 MAPK (CST, 9212), Phospho-RSK1 (S221)/RSK2 (S227) (R&D, AF892-SP), RSK1/2/3 (CST, 9355), Phospho-p70 S6 Kinase (Thr389) (CST, 9205), p70 S6 Kinase (CST, 2708), Phospho-4E-BP1 (Thr37/46) (CST,

(3) HIIT-induced lactate/GPR81 signaling with dual branches converging on ERK1/2 contributes to hippocampal synaptic remodeling and memory improvementFrontiers in Cell and Developmental BiologyJanuary 14, 2026Xuepeng Bian, Qinghui Shang, Lutao Zhu, Jun Liu, Min Wu, Jingjing Li, Shujie LouRAP1 (2399S, CST), PKC (SC-80 Santa), PLC (14247S, CST), Raf1 (9422S, CST), MSK1 (3489S, CST), P90RSK (9355S, CST), ERK (4370T, CST), CREB (9197S, CST), c-Fos (2250S, CST), Zif268 (4154S, CST), NMDAR (5704S, CST),

(4) Combinatorial ERK Inhibition Enhances MAPK Pathway Suppression in BRAF-Mutant MelanomaInt J Mol SciOctober 8, 2025Corinna Kosnopfel, Tobias Sinnberg, Shrunal Mane, Michelle Dongo, Claus Garbe, Heike Niessneragainst MEK1/2 (#4694), p-MEK1/2 (S217/S221) (#9154), ERK1/2 (#9102), p-ERK (T202/Y204) (#4370), RSK1-3 (#9355), p-RSK (T359/S363) (#9344) and GAPDH (#2118) (Cell Signaling Technology, Leiden, The Netherlands) were

(5) RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung AdenocarcinomaCancer ResearchSeptember 2, 2025Alessandro M. Mozzarelli, Antonio Cuevas-Navarro, Emily G. Shuldiner, Martha Vega, Walid K. Chatila, Jierui Xu, Henry S. Walch, Yuzhe Niu, Dmitri A. Petrov, Nikolaus Schultz, et al.(CST; #4695; 1:2,000; RRID:AB_390779), p-ERK1/2 (CST; #4370; 1:2,000; RRID:AB_2315112), RSK1/2/3 (CST; #9355; 1:1,000; RRID:AB_659900), p-RSK (CST; #8753; 1:1,000; RRID:AB_2783561), HA (CST; #3724; 1:4,000; RRID:AB_1549585)

(6) RIT1 Drives Oncogenic Transformation and is an Actionable Target in Lung AdenocarcinomaCancer ResSeptember 2, 2025Alessandro M. Mozzarelli, Antonio Cuevas-Navarro, Emily G. Shuldiner, Martha Vega, Walid K. Chatila, Jierui Xu, Henry S. Walch, Yuzhe Niu, Dmitri A. Petrov, Nikolaus Schultz, et al.(CST; #4695; 1:2,000; RRID:AB_390779), p-ERK1/2 (CST; #4370; 1:2,000; RRID:AB_2315112), RSK1/2/3 (CST; #9355; 1:1,000; RRID:AB_659900), p-RSK (CST; #8753; 1:1,000; RRID:AB_2783561), HA (CST; #3724; 1:4,000; RRID:AB_1549585)

(7) ERK signaling promotes IKKε expression and oncogenic functions in pancreatic cancer cells in association with TBK1Journal of Biological ChemistrySeptember 1, 2025Adam Graves, Angana Mukherjee, Runying Yang, Angie Mordant, Thomas Webb, Kirsten Bryant, Laura Herring, Albert S. BaldwinERK1/2 (CST; catalog no.: 4696), p-RSK S363/T359 (CST; catalog no.: 9344), RSK1/2/3 (CST; catalog no.: 9355), PARP (CST; catalog no.: 9542), and β-Actin (CST; catalog no.: 3700) were purchased from Cell Signaling

(8) CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathwaysJ Exp Clin Cancer ResAugust 5, 2025Jiawei He, Liang Zhang, Hao Xu, Chengtian Gao, Wentao Zhao, Bingchang Zhang, Wanhong Han, Wenpeng Zhao, Guowei Tan, Sifang Chen, et al.anti-Raf-1 (Cat# 9422 S, 1:1000), rabbit anti-p-Raf-1 (Cat# 9421 S, 1:1000), and rabbit anti-Rsk1/2/3 (Cat# 9355 S, 1:1000) from Cell Signaling Technology; mouse anti-E-Cadherin (Cat# 610404, 1:250) from BD Biosciences;

(9) Glycoprotein NMB mediates bidirectional GSC-TAM interactions to promote tumor progressionJCI InsightJuly 8, 2025Yang Liu, Lizhi Pang, Fatima Khan, Junyan Wu, Fei Zhou, Craig Horbinski, Shideng Bao, Jennifer S. Yu, Justin D. Lathia, Peiwen ChenSOX2 (Abcam, ab97959), P-RSK2 (Cell Signaling Technology, 3556S), RSK2 (Cell Signaling Technology, 9355S), P-PYK2 (Cell Signaling Technology, 3291S), PYK2 (Cell Signaling Technology, 3090S), and CD44 (Cell Signaling Technology

(10) HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticityNat CommunMay 26, 2025Stephanie Dobersch, Naomi Yamamoto, Aidan Schutter, Sarah M. Cavender, Tess M. Robertson, Nithya Kartha, Annie N. Samraj, Ben Doron, Lisa A. Poole, Cynthia L. Wladyka, et al.Cell Signaling #11989), anti-pP90 T573 (1:1000, Cell Signaling #8743), anti-P90 (1:1000, Cell Signaling #9355), anti-p4E-BP1 (1:1000, Cell Signaling #2855), anti-4E-BP1 (1:1000, Cell Signaling #9644), anti-pEIF2K

(11) Dopamine Receptor D3 Induces Transient, mTORC1-Dependent Autophagy That Becomes Persistent, AMPK-Mediated, and Neuroprotective in Experimental Models of Huntington's DiseaseCellsApril 29, 2025Diego Luis-Ravelo, Felipe Fumagallo-Reading, Alejandro Febles-Casquero, Jonathan Lopez-Fernandez, Daniel J. Marcellino, Tomas Gonzalez-Hernandez(Cell Signaling Technology; #9206; 1:2000), rabbit monoclonal anti-RPS6KA/p90S6K (Cell Signaling Technology; #9355; 1:2000), rabbit monoclonal anti-phosphoSer380-RPS6KA/p90S6K (Cell Signaling Technology; #11989; 1:2000),

(12) Revisiting phosphoregulation of Cdc25C during M-phase inductioniScienceJanuary 17, 2025Tan Tan, Chuanfen Wu, Ruoning Wang, Bih-Fang Pan, David Hawke, Fumin Yin, Zehao Su, Boye Liu, Sue-Hwa Lin, Wei Zhang, et al.,Santa Cruz Biotechnology,Cat# sc-9986; RRID: AB_672176; RRID: AB_672176 anti-RSK2 for IB,Cell Signaling Technology,Cat# 9355; RRID: AB_659900 anti-phospho-Histone H1,MilliporeSigma,Cat# 06-597 anti-Alix (3A9),Santa Cruz Biotechnology,Cat#

(13) Effect of Oral Lactate Administration on Skeletal Muscle Mass in Mice Under Different Loading ConditionsIn VivoJanuary 3, 2025YOSHITAKA OHNO, MASASHI NAKATANI, YUKI MATSUI, YOHEI SUDA, TAKAFUMI ITO, KOKI ANDO, SHINGO YOKOYAMA, KATSUMASA GOTOCell Signaling), phosphorylated p90RSK Ser380 (p-p90RSK: 11989, Cell Signaling), total p90RSK (t-p90RSK: 9355, Cell Signaling), phosphorylated AMPKα Thr172 (p-AMPK: 2535, Cell Signaling), total AMPKα (t-AMPK: 5831,

(14) YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axisJCI insightDecember 20, 2024Yang W, Zhang M, Zhang TX, Liu JH, Hao MW, Yan X, Gao H, Lei QY, Cui J, Zhou X.(1:2000, 9122), p-ERK1/2 (Thr202/Tyr204) (1:2000, 9101), p-RSK (Thr359) (1:2000, 8753), RSK (1:2000, 9355), p-S6 (Ser235/236) (1:2000, 2211), S6 (1:2000, 2217), p-AKT (Ser473) (1:2000, 4060), and AKT (1:2000,

(15) Analysis of potential TAK1/Map3k7 phosphorylation targets in hypertrophy and cachexia models of skeletal muscleBiology openSeptember 15, 2024Nasehi F, Rylance C, Schnell E, Greene MA, Conway C, Hough Z, Duckett S, Muise-Helmericks RC, Foley AC.(Cell Signaling Technology #4671, 1:1000), p90/Ribosomal s6 kinase (p90RSK) (Cell Signaling Technology #9355T, 1:1000), phospho-RSK (p-p90RSK) (Cell Signaling Technology #9341, 1:1000), p38 (Cell Signaling Technology

(16) Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung CancerCellsSeptember 14, 2024Maietta I, Viscusi E, Laudati S, Iannaci G, D'Antonio A, Melillo RM, Motti ML, De Falco V.membranes were hybridized with the different antibodies. Anti-phospho-S166-MDM2 (#3521), anti-RSK1/2/3 (#9355), anti-phospho-T308-AKT (#9275), anti-Bcl-2 (#2870), anti-phospho-S102-YB1 (#2900) and anti-phospho-T202/Y204-MAPK

(17) The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cellsTranslational OncologyJuly 1, 2024Yulu Chen, Ye Sang, Shiyong Li, Junyu Xue, Mengke Chen, Shubin Hong, Weiming Lv, Kartik Sehgal, Haipeng Xiao, Rengyun Liuanti-phospho-RSK (T359/S363) (#9344S), anti-phospho-CHK2(T68) (#2197T), anti-CHK2 (#6334), anti-RSK1/2/3 (#9355S), anti-phospho-RB (S807/S811) (#8516S), anti-cyclin D1 (#55506S), anti-P27 (#3686S), anti-PARP (#9532S),

(18) Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancersNature cancerJuly 1, 2024Chapeau EA, Sansregret L, Galli GG, Chène P, Wartmann M, Mourikis TP, Jaaks P, Baltschukat S, Barbosa IAM, Bauer D, et al.80076), anti-KRAS (3B10-2F2; Novus, H00003845-M01), anti-RSK1/RSK2/RSK3 (32D7; Cell Signaling Technology, 9355), anti-phospho-MAPK (Thr 202/Tyr 204; Cell Signaling Technology, 9101), anti-phospho-RSK3 (T356/S360;

(19) Differential contribution for ERK1 and ERK2 kinases in BRAFV600E-triggered phenotypes in adult mouse modelsCell Death & DifferentiationJune 1, 2024Giuseppe Bosso, Ana Carolina Cintra Herpst, Oscar Laguía, Sarah Adetchessi, Rosa Serrano, Maria A. Blasco(pRSK) (Thr359/Ser363) 1:1000 (Cell Signaling, 9344), anti-RSK1/2/3 (total RSK) 1:1000 (Cell Signaling, 9355). Anti-phospho RSK and total RSK antibodies were incubated in 5%BSA in TBS-0.1%Tween and the corresponding

(20) Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cellsScience SignalingMay 14, 2024Haibo Zhang, Abigail Read, Christophe Cataisson, Howard H. Yang, Wei-Chun Lee, Benjamin E. Turk, Stuart H. Yuspa, Ji Luophospho-p65/RelA (Ser536) (Cat. #3033), p65/RelA (Cat. #8242), phospho-p90RSK (T359) (Cat. #8753), p90RSK (Cat. #9355), TAK1 (Cat. #5206) and Cyclin D1 (Cat. #2978) were from Cell Signaling Technologies; PPP6C (Cat. #Ab131335)

Be the First to Write a Review!

RSK1/RSK2/RSK3 (32D7) Rabbit mAb

RSK1/RSK2/RSK3 (32D7) Rabbit mAb from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (110)

Reviews

RSK1/RSK2/RSK3 (32D7) Rabbit mAb from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map